Panagora Asset Management’s iBio IBIO Stock Holding History

Panagora Asset Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	–	–	2534
2019 Q2	$0	Sell	1 -1	-50%	-$404	﹤0.01%	2644
2019 Q1	$1K	Hold	2	–	–	﹤0.01%	2478
2018 Q4	$1K	Sell	2 -14	-88%	-$5.42K	﹤0.01%	2423
2018 Q3	$7K	Sell	16 -11	-41%	-$4.45K	﹤0.01%	2329
2018 Q2	$12K	Buy	27 +26	+2,600%	+$19.7K	﹤0.01%	2243
2018 Q1	$1K	Buy	+1	New	+$1.05K	﹤0.01%	2319

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Panagora Asset Management's IBIO Position: Q3 2019 in Review

Panagora Asset Management sold out of iBio (IBIO) in Q3 2019, closing a stake of 1 share.

Panagora Asset Management first reported a position in IBIO in Q1 2018 and held it in 6 quarters. The position peaked at $12K in Q2 2018. 12 funds tracked by Wall St. Rank hold IBIO as of Q3 2019.

Panagora Asset Management reported no remaining iBio position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 1 iBio share in Q3 2019.
Panagora Asset Management first reported a position in iBio in Q1 2018 and held it in 6 quarters.
Panagora Asset Management's iBio position peaked at $12K in Q2 2018.
12 funds tracked by Wall St. Rank held iBio as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.